Our in vitro and in vivo studies help to reconcile our scRNA-seq analysis and identify HSPs, particularly HSP70 family members, as potential new regulators of BCC tumor growth and HH signaling and may offer a novel therapeutic venue for the treatment of BCCs. This evidence concerns the gene HSPA1A and neoplasm.